Haemoglobin binding of a musk xylene metabolite in man

References

• ALBRECHT W. and NEUMANN, H. G., 1985, Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts. Archives of Toxicology, 57, 1–5.
   PubMedGoogle Scholar
• API, A. M., FORD, R. A. and SAN, R. H. C., 1995, An evaluation of musk xylene in a battery of genotoxicity tests. Food and Chemical Toxicology, 33, 1039–1045.
   PubMedGoogle Scholar
• BIRNER, G. and NEUMANN, H. G., 1988, Biomonitoring of aromatic amines II: Hemoglobin binding of some monocyclic aromatic amines. Archives of Toxicology, 62, 110–115.
   PubMed Web of Science ®Google Scholar
• EMIG, M., REINHARDT, A. and MERSCH -SUNDERMANN V., 1996, A comparative study of five nitro musk compounds for genotoxicity in the SOS chromotest and Salmonella mutagenicity. Toxicology Letters, 85, 151–156.
   Google Scholar
• FARMER, P. B., NEUMANN, H.-G. and HENSCHLER, D., 1987, Estimation of exposure of man to substances reacting covalently with macromolecules. Archives of Toxicology, 60, 251–260.
   Google Scholar
• HELBLING, K. S., SCHMID, P. and SCHLATTER, C., 1994, The trace analysis of musk xylene in biological samples: problems associated with its ubiquitous occurrence. Chemosphere, 29, 477–484.
   PubMedGoogle Scholar
• KOKOT -HELBLING, 1995, Critical kinetic aspects of lipophilic compounds. I Volatile organic compounds as food contaminants. II. Musk xylene in humans and laboratory animals. Naturwissenschaftliche Dissertation an der ETH Zurich.
   Google Scholar
• LEHMAN -MCKEEMAN, L. D., CAUDILL, D., YOUNG, J. A. and DlERCKMAN, T. A., 1995, Musk xylene induces and inhibits mouse hepatic cytochrome P-450 2B enzymes. Biochemical and Biophysical Research Communications, 206, 975–980.
   Google Scholar
• LEHMAN -MCKEEMAN, L. D., JOHNSON, D. R. and CAUDILL, D., 1997a, Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene. Toxicology and Applied Pharmacology, 142, 169–177.
   Google Scholar
• LEHMAN -MCKEEMAN, L. D., JOHNSON, D. R., CAUDILL, D. and STUARD, S. B., 1997b, Mechanism based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene. Drug Metabolism and Disposition, 25, 384–389.
   Google Scholar
• LlEBL, B. and EHRENSTOFER, S., 1993, Nitromoschusverbindungen in der Frauenmilch. Gesundheitswesen, 55, 527–532.
   PubMedGoogle Scholar
• MAEKAWA, A., MATSUSHIMA, Y., ONODERA, H., SHIBUTANI, M., OGASAWARA, H., KODAMA, KUROKAWA, Y. and HAYASHI, Y., 1990, Long-term toxicity/carcinogenicity of musk xylol in B6C3F1 mice. Food and Chemical Toxicology, 28, 581–586.
   Google Scholar
• MINEGISHI, K., NAMBARU, S., FUKUOKA, M., TANAK A. and NISHIMAKI -MOGAMI, T., 1991, Distribution, metabolism, and excretion of musk xylene in rats. Archives of Toxicology, 65, 273–282.
   Google Scholar
• MALER, S., SCHMID, P. and SCHLATTER, C., 1996, Occurrence of nitro and non-nitro benzenoid musk compounds in human adipose tissue. Chemosp here, 33, 17–28.
   PubMedGoogle Scholar
• NEUMANN, H. G., 1984, Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Archives of Toxicology, 56, 1–6.
   PubMed Web of Science ®Google Scholar
• NEUMANN, H. G., ALBRECHT, 0., VAN DORP, C. and ZWIRNER -BAlER, I., 1995, Macromolecular adducts caused by environmental chemicals. Clinical Chemistry, 41, 1835–1840.
   Google Scholar
• NEUMANN, H. G., BIRNER, G., KOWALLIK, P., SCHUTZE, D. and ZWIRNER -BAIER, I., 1993, Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment. Environmental Health Perspectives, 99, 65–69.
   Google Scholar
• PEREIRA, M. A., LIN, L.-H. C. and CHANG, L. W., 1981, Dose-dependence of 2-acetylaminofluorene binding to liver DNA and hemoglobin in mice and rats. Toxicology and Applied Pharmacology, 60, 472–478.
   Google Scholar
• PUTMAN, D. L., FORD, R. A., API, A. M., BIGGER, C. A., SAN, R. H. C. and JACOBSON -KRAm, D., 1993, An evaluation of musk xylene in a battery of short-term genotoxicity tests. Toxicologist, 13, 222. RIMIKUS, G. and WOLF, M., 1993, Nachweis von Nitromoschusverbindungen in Frauenmilch und Humanfett. Dtsch. Lebensmittel -Rundschau, 4, 103–107.
   Google Scholar
• SABBIONI, G., 1992, Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for N-oxidation. Chemico-Biological Interactions, 81, 91–117.
   PubMed Web of Science ®Google Scholar
• SABBIONI, G., 1994, Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure-activity relationships. Environmental Health Perspectives, 6, 61-67. SKIPPER, P. L., PENG, X., SOOHOO, C. K. and TANNENBAUM, S. R., 1994, Protein adducts as biomarkers of human carcinogen exposure. Drug Metabolism Reviews, 26, 111–124.
   PubMedGoogle Scholar
• SKIPPER, P. L. and TANNENBAUM, S. R., 1994, Molecular dosimetry of aromatic amines in human populations. Environmental Health Perspectives, 6, 17–21.
   Google Scholar
• TANNENBAUM, S. R. and SKIPPER, P. L., 1994, Quantitative analysis of hemoglobin-xenobiotic adducts. Methods in Enzymology, 231, 625–632.
   PubMedGoogle Scholar
• ZWIRNER -BAlER, I. and NEUMANN, H.-G., 1998, Biomonitoring of aromatic amines: acetylation and deacetylation in the metabolic activation of aromatic amines as determined by hemoglobin binding. Archives of Toxicology 172, 499–504.
   Google Scholar